相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade
Shivani Srivastava et al.
CANCER CELL (2021)
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma
Jianfeng Guo et al.
MOLECULAR CANCER (2021)
Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy
Jinbo Li et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise
Daphne Morel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Targeting metabolic dysregulation for fibrosis therapy
Xiao Zhao et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Christopher Nevala-Plagemann et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Synthetic lethality as an engine for cancer drug target discovery
Alan Huang et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Restoration and Enhancement of Immunogenic Cell Death of Cisplatin by Coadministration with Digoxin and Conjugation to HPMA Copolymer
Yucheng Xiang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency
Ottavia M. Delmonte et al.
BLOOD (2020)
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice
G. Bregni et al.
CANCER TREATMENT REVIEWS (2020)
A novel method to purify adenovirus based on increasing salt concentrations in buffer
Jinhu Ma et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral et al.
NATURE (2020)
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
Rebecca A. Luchtel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
High-dose vitamin C enhances cancer immunotherapy
Alessandro Magri et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity
Joao Manuel Santos et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
Hong-My Nguyen et al.
CELLS (2020)
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
Ya Luo et al.
FRONTIERS IN ONCOLOGY (2020)
An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
Guan Wang et al.
NATURE COMMUNICATIONS (2020)
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers
Maira Di Tano et al.
NATURE COMMUNICATIONS (2020)
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
Nandakumar Packiriswamy et al.
LEUKEMIA (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
Yan Ge et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
Mizuho Sato-Dahlman et al.
CANCERS (2020)
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
Kirsty Taylor et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
Feng-Ying Huang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Regulation of tumor growth by leukocyte-specific protein 1 in T cells
Riri Kwon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The Oncolytic Virus in Cancer Diagnosis and Treatment
Guo-dong Cao et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting immunogenic cell death in cancer
Asma Ahmed et al.
MOLECULAR ONCOLOGY (2020)
Systemic cancer therapy with engineered adenovirus that evades innate immunity
Svetlana Atasheva et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles
Jinhu Ma et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment
Ji Li et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Bin Zhang et al.
MOLECULAR CANCER (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice
Lien Van Hoecke et al.
ONCOIMMUNOLOGY (2020)
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin et al.
NATURE REVIEWS CANCER (2020)
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy
Qianmei Yang et al.
THERANOSTICS (2020)
Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer
Liam Friel Tremble et al.
CANCER LETTERS (2019)
Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy
Peng Lv et al.
NANO LETTERS (2019)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Praveen K. Bommareddy et al.
ONCOIMMUNOLOGY (2019)
Immunogenic cell death in cancer therapy: Present and emerging inducers
Jingyi Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
Sarah Di Somma et al.
FRONTIERS IN ONCOLOGY (2019)
Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors
Ying Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
Huiya Huang et al.
NATURE COMMUNICATIONS (2019)
Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
Mubalake Abudoureyimu et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting cancer vulnerabilities with high-dose vitamin C
Bryan Ngo et al.
NATURE REVIEWS CANCER (2019)
Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
Xi Su et al.
THERANOSTICS (2019)
Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
Ruijing Liang et al.
BIOMATERIALS (2018)
Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges
Julie B. Sneddon et al.
CELL STEM CELL (2018)
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Vitamin C in Stem Cell Reprogramming and Cancer
Luisa Cimmino et al.
TRENDS IN CELL BIOLOGY (2018)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (vol 170, 1109.e1, 2017)
Antoni Ribas et al.
CELL (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma
Marta Diaz-Martinez et al.
CANCER RESEARCH (2018)
Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
Michalis Agathocleous et al.
NATURE (2017)
Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
N. Shenoy et al.
BLOOD CANCER JOURNAL (2017)
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
Wojciech K. Panek et al.
ONCOTARGET (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically
Xiangfei Yuan et al.
CANCER LETTERS (2016)
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
Aldo Pourchet et al.
EBIOMEDICINE (2016)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Revisiting vitamin C and cancer
Colleen R. Reczek et al.
SCIENCE (2015)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cell death modalities: classification and pathophysiological implications
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2007)
Telomerase-specific replication-selective virotherapy for human cancer
T Kawashima et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
